Finance

Beta
Lists
2796:TYO
Pharmarise Holdings Corp
¥500.00
-0.20%
(-1.00) 1D
Jun 5, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2796...
Open
¥500
High
¥502
Low
¥500
Mkt. cap
6.03B
Avg. vol.
9.83K
Volume
5.30K
Dividend
2.80%
Quarterly dividend
¥4
Ex-dividend date
May 28, 2026
52-wk high
¥567
52-wk low
¥479
EPS
-¥14
Shares outstanding
9.24M
No. of employees
2K
Open
¥500
High
¥502
Low
¥500
Mkt. cap
6.03B
Avg. vol.
9.83K
Volume
5.30K
Dividend
2.80%
Quarterly dividend
¥4
Ex-dividend date
May 28, 2026
52-wk high
¥567
52-wk low
¥479
EPS
-¥14
Shares outstanding
9.24M
No. of employees
2K
News stories
From sources across the web
About Pharmarise Holdings Corp
CEOToshimichi Ohno
Employees2.04K
FoundedJun 28, 1984
Headquarters-
SectorDrug
Websitepharmarise.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
16.93B
16.75B
16.85B
16.95B
Cost of goods sold
14.51B
14.52B
14.53B
14.60B
Cost of revenue
14.51B
14.52B
14.53B
14.60B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-1.59B
2.08B
2.08B
2.17B
Operating expense
2.22B
2.08B
2.05B
2.20B
Total operating expenses
16.73B
16.60B
16.58B
16.80B
Operating income
198.00M
153.00M
273.00M
159.00M
Other non operating income
14.00M
21.00M
25.00M
-30.00M
EBT including unusual items
39.00M
132.00M
236.00M
67.00M
EBT excluding unusual items
156.00M
116.00M
239.00M
64.00M
Income tax expense
135.00M
153.00M
108.00M
193.00M
Effective tax rate
346.15%
115.91%
45.76%
-
Other operating expenses
3.05B
-
-
-
Net income
-95.00M
-18.00M
129.00M
-124.00M
Net profit margin
-0.56%
-0.11%
0.77%
-
Earnings per share
-
-
-
-
Interest and investment income
3.00M
3.00M
3.00M
4.00M
Interest expense
-59.00M
-61.00M
-62.00M
-69.00M
Net interest expenses
-56.00M
-58.00M
-59.00M
-65.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
571.25M
526.25M
656.00M
532.25M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer